(Q28204526)

3 January 2024

3

Klaus Müller

0 references

author name string

Hans-Joachim Böhm

series ordinal

2

0 references

Konrad H. Bleicher

series ordinal

1

1 reference

Europe PubMed Central

PubMed ID

12750740

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12750740

3 January 2024

Alexander I. Alanine

series ordinal

4

1 reference

Europe PubMed Central

PubMed ID

12750740

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12750740

full work available at URL

3 January 2024

language of work or name

English

0 references

publication date

May 2003

0 references

http://www.nature.com/articles/nrd1086.pdf

file format

Portable Document Format

1 reference

http://www.nature.com/articles/nrd1086

3 January 2024

1 reference

Nature Reviews Drug Discovery

3 January 2024

published in

0 references

volume

2

0 references

page(s)

369-78

0 references

issue

5

0 references

cites work

Drug discovery: a historical perspective

1 reference

Initial sequencing and analysis of the human genome

31 March 2020

1 reference

A guide to drug discovery: Target selection in drug discovery

31 March 2020

1 reference

31 March 2020

1 reference

Chemical ligands, genomics and drug discovery

31 March 2020

1 reference

ADMET--turning chemicals into drugs

31 March 2020

1 reference

Drugs, leads, and drug-likeness: an analysis of some recently launched drugs

31 March 2020

1 reference

Lead generation--enhancing the success of drug discovery by investing in the hit to lead process

31 March 2020

1 reference

Chemogenomics: bridging a drug discovery gap.

31 March 2020

1 reference

Integration of virtual and high-throughput screening

31 March 2020

1 reference

Prediction of 'drug-likeness'.

31 March 2020

1 reference

Beyond mere diversity: tailoring combinatorial libraries for drug discovery

31 March 2020

1 reference

Development of a virtual screening method for identification of "frequent hitters" in compound libraries

31 March 2020

1 reference

Molecular complexity and its impact on the probability of finding leads for drug discovery

31 March 2020

1 reference

Structure-based screening and design in drug discovery

31 March 2020

1 reference

Structure-based screening of low-affinity compounds

31 March 2020

1 reference

Identification of potent and selective mechanism-based inhibitors of the cysteine protease cruzain using solid-phase parallel synthesis

31 March 2020

1 reference

Parallel solution- and solid-phase synthesis of spiropyrrolo-pyrroles as novel neurokinin receptor ligands

31 March 2020

1 reference

A validation study on the practical use of automated de novo design.

31 March 2020

1 reference

Virtual Screening for Bioactive Molecules by Evolutionary De Novo Design Special thanks to Neil R. Taylor for his help in preparation of the manuscript

31 March 2020

1 reference

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

31 March 2020

1 reference

Comparison of the computer programs DEREK and TOPKAT to predict bacterial mutagenicity. Deductive Estimate of Risk from Existing Knowledge. Toxicity Prediction by Komputer Assisted Technology.

31 March 2020

1 reference

A scoring scheme for discriminating between drugs and nondrugs.

31 March 2020

1 reference

A virtual screening method for prediction of the HERG potassium channel liability of compound libraries

31 March 2020

1 reference

3-D pharmacophores in drug discovery

31 March 2020

1 reference

Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations.

31 March 2020

1 reference

In silico identification of novel therapeutic targets

31 March 2020

1 reference

Identification of four novel human G protein-coupled receptors expressed in the brain

31 March 2020

1 reference

Chemical genetic approaches for the elucidation of signaling pathways

31 March 2020

1 reference

PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors

31 March 2020

1 reference

Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs

31 March 2020

1 reference

Annual Reports in Medicinal Chemistry

31 March 2020

24

35

289

AA Patchett

2000

1 reference